These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16494021)

  • 1. [Study on the preparation and bio-distribution of silybin lipid nanospheres].
    Xu XM; Li Q; Zhu Y; Shen S; Shen Z; Yu JN
    Zhongguo Zhong Yao Za Zhi; 2005 Dec; 30(24):1912-4. PubMed ID: 16494021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new drug nanocrystal self-stabilized Pickering emulsion for oral delivery of silybin.
    Yi T; Liu C; Zhang J; Wang F; Wang J; Zhang J
    Eur J Pharm Sci; 2017 Jan; 96():420-427. PubMed ID: 27575878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
    Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
    Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
    He J; Hou SX; Feng JF; Cai BQ
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
    Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
    Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and liver targeting of floxuridinyl dibutyrate solid lipid nanoparticles].
    Li JJ; Yang GD; Wang HY; Zhang SQ
    Yao Xue Xue Bao; 2008 Jul; 43(7):761-5. PubMed ID: 18819483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration.
    Han X; Wang Z; Wang M; Li J; Xu Y; He R; Guan H; Yue Z; Gong M
    Drug Deliv; 2016 Jun; 23(5):1818-29. PubMed ID: 26556526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronization of silybin by the emulsion solvent diffusion method.
    Zhang ZB; Shen ZG; Wang JX; Zhang HX; Zhao H; Chen JF; Yun J
    Int J Pharm; 2009 Jul; 376(1-2):116-22. PubMed ID: 19409464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
    Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
    Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin.
    Li X; Huang Y; Chen X; Zhou Y; Zhang Y; Li P; Liu Y; Sun Y; Zhao J; Wang F
    J Drug Target; 2009 Dec; 17(10):739-50. PubMed ID: 19863195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silybin nanoparticles for liver cancer: development, optimization and in vitro - in vivo evaluation.
    Zhang H; Wang CB; Liu JL
    J BUON; 2016; 21(3):633-44. PubMed ID: 27569084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles.
    Yu JN; Zhu Y; Wang L; Peng M; Tong SS; Cao X; Qiu H; Xu XM
    Acta Pharmacol Sin; 2010 Jun; 31(6):759-64. PubMed ID: 20523347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
    Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
    J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Targeting Albumin-Coated Silybin-Phospholipid Particles Prepared by Nab™ Technology for Improving Treatment Effect of Acute Liver Damage in Intravenous Administration.
    Lu C; Li X; Liang X; Zhang X; Yin T; Gou J; He H; Zhang Y; Tang X
    AAPS PharmSciTech; 2019 Aug; 20(7):293. PubMed ID: 31432294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and evaluation of silybin nanocrystallines self-stabilizing Pickering emulsion].
    Zhang JF; Liu C; Zhang J; Yi T
    Yao Xue Xue Bao; 2016 May; 51(5):813-20. PubMed ID: 29878730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of silybin nanosuspensions targeting liver.
    Wang Y; Wang L; Liu Z; Zhang D; Zhang Q
    J Biomed Nanotechnol; 2012 Oct; 8(5):760-9. PubMed ID: 22888746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body distribution of camptothecin solid lipid nanoparticles after oral administration.
    Yang S; Zhu J; Lu Y; Liang B; Yang C
    Pharm Res; 1999 May; 16(5):751-7. PubMed ID: 10350020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.
    Yanyu X; Yunmei S; Zhipeng C; Qineng P
    Int J Pharm; 2006 Jan; 307(1):77-82. PubMed ID: 16300915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
    Xu D; Ni R; Sun W; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Apr; 41(4):552-9. PubMed ID: 24495272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phyto-liposomes as nanoshuttles for water-insoluble silybin-phospholipid complex.
    Angelico R; Ceglie A; Sacco P; Colafemmina G; Ripoli M; Mangia A
    Int J Pharm; 2014 Aug; 471(1-2):173-81. PubMed ID: 24858381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.